Cisplatin combination chemotherapy in squamous cell carcinoma and adenoid cystic carcinoma of the skin

J Dermatol. 1989 Jun;16(3):227-30. doi: 10.1111/j.1346-8138.1989.tb01254.x.


Seven patients with skin cancers, six with squamous cell carcinoma (SCC) and one with adenoid cystic carcinoma, were treated with cisplatin in combination with vindesine or adriamycin. Partial response was observed in three patients with squamous cell carcinomas: two cases with metastatic lung lesions and one with a primary skin lesion and lymph node metastasis. Two of the responding SCC had been resistant to previous chemotherapy, including peplomycin and mitomycin C. Multiple metastatic lesions of adenoid cystic carcinoma of the skin completely regressed after two courses of the combination chemotherapy with cisplatin and adriamycin. This report showed that cisplatin combination chemotherapy may be useful for the treatment of cutaneous squamous cell carcinoma, which is resistant to peplomycin, and adenoid cystic carcinoma of the skin.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Adenoid Cystic / drug therapy*
  • Carcinoma, Squamous Cell / drug therapy*
  • Cisplatin / administration & dosage*
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Male
  • Middle Aged
  • Skin Neoplasms / drug therapy*
  • Vindesine / administration & dosage


  • Doxorubicin
  • Cisplatin
  • Vindesine